blog

The network of urologists who provide the Giasay® PROSTATE test is gradually expanding. Today, you can take the highly accurate prostate cancer test at specialist

First Patent Certificate for EP Patent No. 3 775 909 for us! Availabe here.

The Glycanostics cancer screening technology detects glycan changes (complex carbohydrates) attached to a protein in the blood. It is highly scalable  due to the following

8th & 9th March, 2023, Brussels Our CEO Eva Kováčová is one of the organisers of the first summit by the EU Female Founders in

Glycanostics took another important step to improve its quality management system and has been granted with ISO 13485.

Glycanostics was selected as one of eight most innovative companies to participate in the MEDICAL FORGE Accelerator program 2023, which will facilitate and accelerate our

Glycanostics was invited to attend the EIC Summit that took place on 7th and 8th December in Brussels. We have spent two days learning about

Glycanostics was honoured to be invited for the EIC Corporate Day with Medtronic and Fresenius Kabi in November 2022. We presented our innovative approach to

Glycanostics, Ltd. hosted an important visit – 17 ambassadors from different countries from Asia, Europe, South America and USA. We introduced them our company, explained the

Europe’s largest biotech partnering conference Bio Europe brings together key players in biotech industry, key decision-makers, most innovative companies and Glycanostics was among them. We

Glycanostics, Ltd. as a regional winner, was selected from more than 10 000 start-ups around the world to attend and compete at Startup World Cup 2022 in San Francisco.

Glycanostics was invited to attend 1st Pan-European Hospital and Healthcare Procurement Summit  in Brussels as a recipient of EIC Accelerator grant.  We presented our solutions for